PhD student Thijs Meenink unveils his surgical robot for ophthalmological procedures, an untapped market in the U.S.
MASSDEVICE ON CALL — A new surgical robot designed to bring ease and precision to eye surgeries may hit the market, if inventor Thijs Meenink can defend his PhD thesis work on the machine.
Meenink, a student at Eindhoven University of Technology, plans to commercialize the novel robot after he obtains his doctorate.
House Republicans target the FDA's review and approval process of medical devices with 10 new bills.
MASSDEVICE ON CALL —House Republicans introduced 10 bills aimed at the FDA's medical device review and approval process.
The 10 bills, sent to the Energy & Commerce Committee, detailed proposed measures to reform the predictability, consistency and transparency of the federal watchdog agency's med-tech review process.
Used pacemakers taken from the dead are successfully implanted in patients who could not afford a new model.
MASSDEVICE ON CALL — Pacemakers taken from funeral homes in the U.S. have been sent to India and successfully implanted in new patients thanks to researchers from the University of Texas Health Science Center.
Their research proved that used pacemakers can be refurbished and turned over to patients who could not afford a new device.
The top seven medical device stories for the week of October 17, 2011.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.
The top three medical device stories for October 14, 2011.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com's coverage highlights our three biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
A Harvard cancer specialist looks for lessons in the potentially avoidable death of former Apple CEO and tech guru Steve Jobs, whose headstrong insistence on alternative medicine may have helped hasten his death.
Steve Jobs, the tech visionary and founder of Apple Inc. (NSDQ:AAPL) who died earlier this month after a long struggle with cancer, may have been saved had he stuck with conventional medicine, according to a cancer specialist.
Jobs may have gone as long as two years without conventional cancer treatment, opting instead for "alternative mumbo jumbo" while his cancer likely spread through his body, Harvard Medical School researcher Ramzi Amri wrote.
Former Apple CEO and tech guru Steve Jobs leaves his mark on the health care world before passing away from pancreatic cancer.
MASSDEVICE ON CALL — Steve Jobs, technology visionary and founder of Apple Inc. (NSDQ:AAPL), passed away from complications tied to his long and public struggle with pancreatic cancer, but not without leaving his mark on health care.
Apple's iPhone and iPad have become a regular presence in clinics, and apps designed to help patients and doctors manage care further blur the lines between entertainment technology and information technology.